Moolec director reports option holdings in Form 3

Moolec Science SA director Daniel Joaquin Core filed a Form 3 reporting existing equity awards rather than any new share purchases or sales.

Rhea-AI Filing Summary

Moolec Science SA director Daniel Joaquin Core filed a Form 3 reporting existing equity awards rather than any new share purchases or sales. He reports direct holdings of options over 934 ordinary shares at an exercise price of $7.14 expiring on June 30, 2031, plus separate option holdings over 933 shares expiring on June 30, 2032 and another 933 shares expiring on June 30, 2033.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Core Daniel Joaquin

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--

Holdings After Transaction: Ordinary shares — 2,800 contracts (Direct)

Key Figures

Option exercise price: $7.14 per share Underlying shares 2031 grant: 934 ordinary shares Underlying shares 2032 grant: 933 ordinary shares +1 more

4 metrics

Option exercise price $7.14 per share Exercise price for reported share options

Underlying shares 2031 grant 934 ordinary shares Share option expiring June 30, 2031

Underlying shares 2032 grant 933 ordinary shares Share option expiring June 30, 2032

Underlying shares 2033 grant 933 ordinary shares Share option expiring June 30, 2033

Key Terms

Ordinary shares, Share Option, exercise price, expiration date

4 terms

Ordinary shares financial

"security_title: "Ordinary shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Share Option financial

"underlying_security_title: "Share Option""

exercise price financial

"conversion_or_exercise_price: "7.1400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2031-06-30T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Moolec Science (MLEC) Form 3 for Daniel Joaquin Core show?

The Form 3 shows director Daniel Joaquin Core’s existing equity awards in Moolec Science SA. It reports direct holdings of options over blocks of ordinary shares at a fixed exercise price, without indicating any recent purchases or sales of the company’s stock.

Did Daniel Joaquin Core buy or sell Moolec Science (MLEC) shares in this Form 3?

No specific buys or sells are shown in this Form 3. The entries are labeled as holdings, with transaction codes marked as unknown and no share amounts reported as bought or sold, indicating disclosure of existing option positions rather than new trading activity.

What stock option terms are disclosed for Daniel Joaquin Core at Moolec Science (MLEC)?

The filing discloses options over ordinary shares with an exercise price of $7.14 per share. One grant covers 934 underlying shares expiring on June 30, 2031, while two other grants each cover 933 shares expiring on June 30, 2032 and June 30, 2033.

How are Daniel Joaquin Core’s Moolec Science (MLEC) holdings characterized in the Form 3?

All reported positions are categorized as direct ownership in ordinary shares through share options. Each entry is a holding with no reported transaction price per share and no indicated buy or sell direction, focusing on option terms like exercise price and expiration dates.

What is the significance of the expiration dates on Moolec Science (MLEC) options in this Form 3?

The expiration dates, running from June 30, 2031 through June 30, 2033, show how long Daniel Joaquin Core can exercise these options at $7.14 per share. After each respective expiration date, the related option grant would no longer be exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Core Daniel Joaquin

(Last) (First) (Middle)

29 MARSHEPAUG ROAD

(Street)

GOSHEN CONNECTICUT 06756-2115

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/15/2026

3. Issuer Name and Ticker or Trading Symbol
Moolec Science SA [ MLEC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ordinary shares	04/15/2026	06/30/2031	Share Option	934	$7.14	D
Ordinary shares	06/30/2027	06/30/2032	Share Option	933	$7.14	D
Ordinary shares	06/30/2028	06/30/2033	Share Option	933	$7.14	D

Explanation of Responses:

	/s/ Daniel Core	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)